Day: August 16, 2021

JACKSONVILLE, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) —  LFTD Partners Inc., formerly known as Acquired Sales Corp. (OTCQX: AQSP) (www.AcquiredSalesCorp.com), today announced that during the second quarter of 2021 it achieved quarter-over-quarter growth in revenue of 99%, from $3,353,270 to $6,695,144, quarter-over-quarter growth in net income of 158%, from $618,359 to $1,596,154, and quarter-over-quarter growth in basic earnings per share of 75%, from $0.08 to $0.14, driven by the growth of its wholly-owned subsidiary Lifted Made (www.LiftedMade.com), maker of the award-winning Urb Finest Flowers brand of hemp-derived delta-8-THC, delta-9-THC, delta-10-THC and other emerging cannabinoid products. Nicholas S. Warrender, Vice Chairman and COO of AQSP, and founder and CEO of Lifted Made, said: “The second quarter is a solid reflection...

Gross Margin Exceeds 30% on Increasing ASP and Solid Operational Execution; Completes Uplist to NASDAQ and $25 Million Public Offering Manchester, NH, Aug. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Minim, Inc. (NASDAQ: MINM) (“Minim”), the creator of intelligent networking products under the globally recognized Motorola brand, today reported second quarter financial results for the period ended June 30, 2021. Q2 2021 Financial Highlights:Net revenue of $14.9 million, up 45% year over year from $10.3 million in Q2 2020, exceeding the growth rate of 26% recorded in Q2 2020. Revenue Bookings of $15.6 million; total deferred revenue as of June 30, 2021 increased 279% compared to Q1 2021. Continued improvement in gross margin at 30.1%, up 940 basis points year-over-year compared to 20.7% in Q2 2020. Net loss of $1.6 million,...

ROSELAND, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter ended June 30, 2021. Arjan Haverhals, President and Chief Executive Officer of Milestone Scientific, commented, “We achieved a fourteen-fold increase in revenue to $2.4 million versus $168,000 for the same period last year, reflecting the strong recovery in our dental business, as well as the initial impact of our new sales and marketing initiatives. Importantly, our dental segment remains cash flow positive on a standalone basis with continued growth opportunities. In terms of our CompuFlo® Epidural and CathCheck™ Systems, we are beginning to see the...

TORONTO, Aug. 16, 2021 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“) today released its financial results for the three and six months ended June 30, 2021. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares (“Shares”) and per Share amounts. Q2 2021 Highlights and Subsequent EventsTotal net revenues from sale of adult use cannabis in Canada of $20.9 million for the three months ended June 30, 2021, more than doubling the same period in 2020 and Q1 2021 Adjusted EBITDA improves to negative $3.3 million, an improvement of $7.2 million as compared to Q2 2020 and $3.4 million more than the previous quarter Continuing improvements in total...

MOSCOW, Aug. 16, 2021 (GLOBE NEWSWIRE) — HeadHunter Group PLC (Nasdaq: HHR, MOEX: HHRU) announced today its financial results for the quarter ended June 30, 2021. As used below, references to “we,” “our,” “us” or the “Company” or similar terms shall mean HeadHunter Group PLC. Second Quarter 2021 Financial and Operational Highlights(in millions of RUB(1) and USD(2))Three months ended June 30, 2021 Three months ended June 30, 2020 Change(3) Three months ended June 30, 2021RUB RUB   USD(4)Revenue 3,911 1,534 155.0% 54.0Russia Segments(6) Revenue 3,593 1,421 152.8% 49.6Net Income 1,279 239 435.1% 17.7Net Income Margin, % 32.7% 15.6% 17.1 ppts  Adjusted EBITDA(5)(7) 2,264 666 239.9% 31.3Adjusted EBITDA Margin, %(5)(7) 57.9% 43.4% 14.5 ppts  Adjusted Net Income(5)(7) 1,603 358 347.1% 22.1Adjusted Net Income...

BARRIE, Ontario, Aug. 16, 2021 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in research-driven development and manufacturing of cannabis API and finished dose products today announced its financial results for the three and six months ended June 30, 2021, a period of ongoing progress in establishing itself as an international pharmaceutical company specializing in cannabis. Second Quarter Overview “In Q2 2021, we were awarded one of the most difficult to achieve North American GMP certifications to establish ourselves and as a true pharmaceutical company while continuing to deliver our international medical cannabis sales,” said Keith Strachan, President and Interim CEO, MediPharm. “We underwent a Health Canada audit for a pharmaceutical...

Enrollment continues in Phase 1/2a trial evaluating LAVA-051 in hematological malignancies CTA accepted and IND cleared for Phase 1/2a trial evaluating LAVA-1207 in metastatic castrate resistant prostate cancer; on track to begin later this year Collaboration with Janssen Biotech, Inc. remains on track and progressing towards potential milestones Cash balance of $151 million expected to fund operations into the second half of 2023 UTRECHT, The Netherlands and PHILADELPHIA, Aug. 16, 2021 (GLOBE NEWSWIRE) —  LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company focused on developing bispecific gamma-delta T cell engagers (bsTCEs) to transform the treatment of cancer, today announced financial results for the second quarter ended June 30, 2021 and recent corporate highlights. “We continue our strong execution,...

Bestyrelsen for Investeringsforeningen IA Invest har i dag den 16. august 2021 godkendt foreningens halvårsrapport for 2021. Rapporten, der ikke er revideret, er vedhæftet denne meddelelse. Halvårsrapporten kan endvidere downloades fra foreningens hjemmeside samt rekvireres ved henvendelse til Invest Administration A/S, Badstuestræde 20, 1209 København K, tlf. 3814 6600. Med venlig hilsen Bestyrelsenfor Investeringsforeningen IA InvestAttachmentIA Invest – Halvårsrapport 2021